From the Editor

Maddening therapies: How hallucinogens morphed into novel treatments

In medicine we must always expect the unexpected. Medicine is replete with paradoxes, where poisons become cures.


 

References

Snake venom is deadly but is being used to treat some cancers,1 because it produces contortrostatin, a protein that “paralyzes” cancer cells and prevents them from migrating. Venoms from spiders are being investigated as a treatment to slow the progression of muscular dystrophy by preventing muscle cells from deteriorating. Venom from tarantulas can relieve chronic pain, and those from centipedes help rodents tolerate thermal, chemical, or acid pain. Scorpion venom can cause cancer cells to glow under a flashlight, enabling surgeons to locate and remove them. Anemones toxin could be used to treat autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, and lupus.

Vaccines are an excellent example of how deadly pathogens can be transformed into life-saving therapies. Billions of people have been protected from polio, smallpox, tetanus, diphtheria, measles, mumps, rubella, influenza, pneumococcus, hepatitis A and B, rabies, shingles, typhoid, meningitis, or cholera. Turning killers into saviors is one of the most remarkable miracles of medical research.2

The mind-boggling transformation of mind-altering drugs

In psychiatry, psychedelic drugs have been repurposed into useful therapies for mental illness. As recently as a decade ago, psychiatric practitioners—physicians and nurse practitioners—regarded hallucinogens as dangerous, “must-avoid” drugs of abuse that could trigger or exacerbate serious psychiatric disorders. Then, thanks to ongoing research, the psychedelic “caterpillars” transformed into therapeutic “butterflies,” and the despised drugs of abuse became welcome adjuncts for treating some stubborn psychopathologies. Such paradoxical developments are emblematic of how one can always find a silver lining.

Consider the following transformations of various psychedelics and hallucinogens—also called “entheogens”—into novel pharmacotherapies. Note that in most cases, the application of these mind-altering drugs into useful medications is still a work in progress.

Pages

Recommended Reading

We can work it out: Should I hire my patient?
MDedge Psychiatry
Trump administration to focus on ACA reform, tort reform
MDedge Psychiatry
Slavitt to Trump administration: Keep the CMS Innovation Center
MDedge Psychiatry
House passes 21st Century Cures bill
MDedge Psychiatry
Trump HHS nominee could curb regulations, reshape health insurance
MDedge Psychiatry
Senate sends 21st Century Cures bill to president
MDedge Psychiatry
Serious mental illness gets serious attention in 21st Century Cures Act
MDedge Psychiatry
First addiction medicine certification exam slated for fall 2017
MDedge Psychiatry
Diabetes, ischemic heart disease, pain lead health spending
MDedge Psychiatry
Hawaii continues to top ‘America’s Health Rankings’
MDedge Psychiatry